Search

Your search keyword '"Johan Courjon"' showing total 94 results

Search Constraints

Start Over You searched for: Author "Johan Courjon" Remove constraint Author: "Johan Courjon"
94 results on '"Johan Courjon"'

Search Results

1. Efficacy of an antimicrobial stewardship intervention for early adaptation of antibiotic therapy in high-risk neutropenic patients

2. What Place Is There for Long-Acting Antibiotics in the Management of Gram-Positive Infections? A Qualitative Cross-Sectional Study

3. Time-to-detection in culture of Mycobacterium tuberculosis: performance for assessing index cases contact-positivity

4. Corrigendum to 'Infectious disease symptoms and microbial carriage among French medical students travelling abroad: A prospective study' [Travel Med Infect Dis 34 (2020 Mar–Apr) 101548]

5. Breakthrough infections due to SARS-CoV-2 Delta variant: relation to humoral and cellular vaccine responses

6. COVID-19 patients age, comorbidity profiles and clinical presentation related to the SARS-CoV-2 UK-variant spread in the Southeast of France

7. Dalbavancin treatment for prosthetic joint infections in real-life: a national cohort study and literature review

8. Management of prosthetic joint infections in France: a national audit to identify key situations requiring innovation and homogenization

9. Accurate Detection of SARS-CoV-2 by Next-Generation Sequencing in Low Viral Load Specimens

10. Efficacy and safety of anakinra in adults presenting deteriorating respiratory symptoms from COVID-19: A randomized controlled trial

11. Case Report: Autoimmune Hemolysis Anemia After Dihydroartemisinin and Piperaquine for Uncomplicated Plasmodium falciparum Malaria

12. Clindamycin Efficacy for Cutibacterium acnes Shoulder Device-Related Infections

13. Proteinuria as a Biomarker for COVID-19 Severity

14. Functional Exhaustion of Type I and II Interferons Production in Severe COVID-19 Patients

15. Patients with community-acquired bacteremia of unknown origin: clinical characteristics and usefulness of microbiological results for therapeutic issues: a single-center cohort study

16. EDIN-B Promotes the Translocation of Staphylococcus aureus to the Bloodstream in the Course of Pneumonia

17. Pyogenic vertebral osteomyelitis of the elderly: Characteristics and outcomes.

18. Antiviral drugs in hospitalized patients with COVID-19 - the DisCoVeRy trial

19. Characteristics, management, and outcomes of patients with infectious encephalitis requiring intensive care: A prospective multicentre observational study

20. Obesity, diabetes, hypertension and severe outcomes among inpatients with coronavirus disease 2019: a nationwide study

23. Heterogeneous NLRP3 inflammasome signature in circulating myeloid cells as a biomarker of COVID-19 severity

24. MPox virus: an unusual aetiology of peritonitis

25. Clindamycin Efficacy for

26. An open-label randomized, controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19 – Final results from the DisCoVeRy trial

27. Cotrimoxazole for community-acquired urinary tract infections leads to more adverse effects than fluoroquinolones

28. Erythematous skin nodules during treatment of Whipple's disease

29. French national cohort of first use of dalbavancin: A high proportion of off-label use

30. Efficacy and safety of anakinra in adults presenting deteriorating respiratory symptoms from COVID-19: A randomized controlled trial

31. Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19

32. Author response for 'Influenza vaccination and prognosis of COVID ‐19 in hospitalized patients with diabetes: Results from the CORONADO study'

33. COVID-19 patients age, comorbidity profiles and clinical presentation related to the SARS-CoV-2 UK-variant spread in the Southeast of France

34. Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial

35. A Prospective Cohort Study to Identify Clinical, Biological, and Imaging Features That Predict the Etiology of Acute Encephalitis

36. Autoimmune Hemolysis Anemia After Dihydroartemisinin and Piperaquine for Uncomplicated Plasmodium Falciparum Malaria

37. An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19

38. Management of prosthetic joint infections in France: a national audit to identify key situations requiring innovation and homogenization

39. Spread of the SARS-CoV-2 UK-variant in the South East of France: impact on COVID-19 patients’ age, comorbidity profiles and clinical presentation

40. Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic

41. Escherichia coli Rho GTPase-activating toxin CNF1 mediates NLRP3 inflammasome activation via p21-activated kinases-1/2 during bacteraemia in mice

42. Dalbavancin treatment for prosthetic joint infections in real-life: a national cohort study and literature review

43. A Population Pharmacokinetic Analysis of Continuous Infusion of Cloxacillin during Staphylococcus aureus Bone and Joint Infections

44. Functional Exhaustion of Type I and II Interferons Production in Severe COVID-19 Patients

45. A Population Pharmacokinetic Analysis of Continuous Infusion of Cloxacillin during

46. QT Interval Prolongation Under Hydroxychloroquine/Azithromycin Association for Inpatients With SARS‐CoV‐2 Lower Respiratory Tract Infection

48. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

49. Epidemiology of human common coronavirus acquisition in pilgrims

50. Cefoxitin-based antibiotic therapy for extended-spectrum β-lactamase-producing Enterobacteriaceae prostatitis: a prospective pilot study

Catalog

Books, media, physical & digital resources